Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Introduction: Since positive blood cultures are uncommon in patients with nosocomial pneumonia (NP), the responsible pathogens are usually isolated from respiratory samples. Studies on bacteremia associated with hospital-acquired pneumonia (HAP) have reported fatality rates of up to 50%. The purpose of the study is to compare risk factors, pathogens and outcomes between bacteremic nosocomial pneumonia (B-NP) and nonbacteremic nosocomial pneumonia (NB-NP) episodes. Methods: This is a prospective, observational and multicenter study (27 intensive care units in nine European countries). Consecutive patients requiring invasive mechanical ventilation for an admission diagnosis of pneumonia or on mechanical ventilation for > 48 hours irrespective of admission diagnosis were recruited. Results: A total of 2,436 patients were evaluated; 689 intubated patients presented with NP, 224 of them developed HAP and 465 developed ventilation-acquired pneumonia. Blood samples were extracted in 479 (69.5%) patients, 70 (14.6%) being positive. B-NP patients had higher Simplified Acute Physiology Score (SAPS) II score (51.5 ± 19.8 vs. 46.6 ± 17.5, P = 0.03) and were more frequently medical patients (77.1% vs. 60.4%, P = 0.01). Mortality in the intensive care unit was higher in B-NP patients compared with NB-NP patients (57.1% vs. 33%, P < 0.001). B-NP patients had a more prolonged mean intensive care unit length of stay after pneumonia onset than NB-NP patients (28.5 ± 30.6 vs. 20.5 ± 17.1 days, P = 0.03). Logistic regression analysis confirmed that medical patients (odds ratio (OR) = 5.72, 95% confidence interval (CI) = 1.93 to 16.99, P = 0.002), methicillin-resistant Staphylococcus aureus (MRSA) etiology (OR = 3.42, 95% CI = 1.57 to 5.81, P = 0.01), Acinetobacter baumannii etiology (OR = 4.78, 95% CI = 2.46 to 9.29, P < 0.001) and days of mechanical ventilation (OR = 1.02, 95% CI = 1.01 to 1.03, P < 0.001) were independently associated with B-NP episodes. Bacteremia (OR = 2.01, 95% CI = 1.22 to 3.55, P = 0.008), diagnostic category (medical patients (OR = 3.71, 95% CI = 2.01 to 6.95, P = 0.02) and surgical patients (OR = 2.32, 95% CI = 1.10 to 4.97, P = 0.03)) and higher SAPS II score (OR = 1.02, 95% CI = 1.01 to 1.03, P = 0.008) were independent risk factors for mortality. Conclusions: B-NP episodes are more frequent in patients with medical admission, MRSA and A. baumannii etiology and prolonged mechanical ventilation, and are independently associated with higher mortality rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the context of pneumonia, as well as other focal infections caused by aerobic Gram-negative bacilli, bacteremia is strongly associated with sepsis and death (13,14).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [14]
In the citing paper
“We reasoned that the bloodstream dissemination of microorganisms from the primary site of infection is a critical complication in Gram-negative bacterial infections.”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Fagon, J.-Y., Chastre, J., Hance, A. J., Montravers, P., Novara, A., & Gibert, C. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90060-3 · Cited by 1,180 · cited 1×
“baumannii exhibits an intrinsic resistance to multiple antimicrobial agents and generates a continuing controversy about whether VAP caused by this microorganism increases morbidity and mortality independently of the effect of other confounding factors in the ICU setting [22-25].”
BackgroundVentilator-associated Pneumonia Caused by Potentially Drug-resistant Bacteria
TROUILLET, J.-L., CHASTRE, J., VUAGNAT, A., JOLY-GUILLOU, M.-L., COMBAUX, D., DOMBRET, M.-C., & GIBERT, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9705064 · Cited by 885 · cited 1×
“There are several factors linked with MRSA isolation in VAP episodes: administration of antibiotics before the development of VAP [ 29 ,30] and the length of hospital stay rather than the period of mechanical ventilation were strongly associated with MRSA isolation [31].”
BackgroundThe Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
RELLO, J., GALLEGO, M., MARISCAL, D., SOÑORA, R., & VALLES, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9607030 · Cited by 467 · cited 1×
“Since positive blood cultures are uncommon in nosocomial pneumonia (NP) patients, the responsible pathogens are usually isolated from respiratory samples [1-3].”
BackgroundSelf-citationRELLO, J., SA-BORGES, M., CORREA, H., LEAL, S.-R., & BARAIBAR, J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9812034 · Cited by 352 · cited 2×
“Prior antibiotic exposure was considered when a patient received antimicrobial agents during the 15 days preceding the NP episode, with the exception of antibiotics administered for surgical prophylaxis [13].”
BackgroundSelf-citationNosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment
Cisneros, J. M., & Rodríguez-Baño, J. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00487.x · Cited by 322 · cited 1×
“baumannii exhibits an intrinsic resistance to multiple antimicrobial agents and generates a continuing controversy about whether VAP caused by this microorganism increases morbidity and mortality independently of the effect of other confounding factors in the ICU setting [22-25].”
Background
Research works printed but not linked: 1
- Menzies BE The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections Curr Opin Infect Dis 2003 16 225 229 12821812 · DOI · Paper page
Cited by
Chang, Y.-T., Lin, C.-Y., Chen, Y.-H., & Hsueh, P.-R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00893 · Cited by 419
Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study
Koulenti, D., Tsigou, E., & Rello, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2703-z · Cited by 392
Self-citationNarrow-spectrum antibacterial agents
Melander, R. J., Zurawski, D. V., & Melander, C. (2018) · MedChemComm · doi:10.1039/c7md00528h · Cited by 226
The lung is a host defense niche for immediate neutrophil-mediated vascular protection
Yipp, B. G., Kim, J. H., Lima, R., Zbytnuik, L. D., Petri, B., Swanlund, N., Ho, M., Szeto, V. G., Tak, T., Koenderman, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam8929 · Cited by 213
Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis
Weber, G. F., Chousterman, B. G., Hilgendorf, I., Robbins, C. S., Theurl, I., Gerhardt, L. M. S., Iwamoto, Y., Quach, T. D., Ali, M., Chen, J. W., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131471 · Cited by 151
Acelas, A. L. R., Almeida, M. D. A., Engelman, B., & Cañón-Montañéz, W. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.08.016 · Cited by 154
Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia
Michels, K. R., Zhang, Z., Bettina, A. M., Cagnina, R. E., Stefanova, D., Burdick, M. D., Vaulont, S., Nemeth, E., Ganz, T., & Mehrad, B. (2017) · JCI Insight · doi:10.1172/jci.insight.92002 · Cited by 93
“focal infections caused by aerobic Gram-negative bacilli, bacteremia is strongly associated with sepsis and death (13, 14).”
BackgroundThe Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia
Rangel, S. M., Diaz, M. H., Knoten, C. A., Zhang, A., & Hauser, A. R. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004945 · Cited by 84
“Hospital-acquired pneumonia (HAP) is a severe form of nosocomial infection associated with attributable mortality rates of approximately 30% [1].”
Hypoxia Modulates Infection of Epithelial Cells by Pseudomonas aeruginosa
Schaible, B., McClean, S., Selfridge, A., Broquet, A., Asehnoune, K., Taylor, C. T., & Schaffer, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056491 · Cited by 69
“Intensive care mortality rates are significantly higher for bacteremic pneumonia compared to nonbacteremic pneumonia [40].”
BackgroundPseudomonas aeruginosa: breaking down barriers
Berube, B. J., Rangel, S. M., & Hauser, A. R. (2015) · Current Genetics · doi:10.1007/s00294-015-0522-x · Cited by 79
Behnia, M. M., Logan, S. C., Fallen, L., & Catalano, P. W. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-232 · Cited by 67
Hu, Y., Liu, A., Vaudrey, J., Vaiciunaite, B., Moigboi, C., McTavish, S. M., Kearns, A., & Coates, A. R. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117664 · Cited by 61
“aureus (MRSA) cause significant morbidity and mortality and are associated with an array of life-threatening infections including surgical site infections, bacteremia, pneumonia and catheter-associated infections [5,6].”
BackgroundJONG, A. D., Verzilli, D., Sebbane, M., Monnin, M., Belafia, F., Cissé, M. F., Conseil, M., Carr, J., Jung, B., Chanques, G., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002954 · Cited by 61
Shields, R. K., Clancy, C. J., Minces, L. R., Kwak, E. J., Silveira, F. P., Abdel-Massih, R. C., Toyoda, Y., Bermudez, C. A., Bhama, J. K., Shigemura, N., et al. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.012 · Cited by 61
Identification of Streptococcus pneumoniae in hospital-acquired pneumonia in adults
Suaya, J. A., Fletcher, M. A., Georgalis, L., Arguedas, A. G., McLaughlin, J. M., Ferreira, G., Theilacker, C., Gessner, B. D., & Verstraeten, T. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.09.036 · Cited by 54
Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
Elmassry, M. M., Colmer‐Hamood, J. A., Kopel, J. J., Francisco, M. J. S., & Hamood, A. N. (2023) · Microorganisms · doi:10.3390/microorganisms11040916 · Cited by 53
Gotts, J. E., Bernard, O., Chun, L. F., Croze, R. H., Ross, J. T., Nesseler, N., Wu, X., Abbott, J. A., Fang, X., Calfee, C. S., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00132.2019 · Cited by 52
Prazak, J., Valente, L. G., Iten, M., Federer, L., Grandgirard, D., Soto, S., Resch, G., Leib, S. L., Jakob, S. M., Hænggi, M., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab112 · Cited by 61
“In humans, bacteraemia appears to be a major predictor of mortality for patients with VAP [18, 19].”
BackgroundInfluentialLee, Y.-T., Kuo, S., Yang, S.-P., Lin, Y.-T., Chiang, D.-H., Tseng, F., Chen, T.-L., & Fung, C.-P. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03988.x · Cited by 48
Timsit, J., Huntington, J. A., Wunderink, R. G., Shime, N., Kollef, M. H., Kivistik, Ü., Nováček, M., Réa-Neto, Á., Martín‐Loeches, I., Yu, B., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03694-3 · Cited by 53
The structure of the polysaccharide isolated from Acinetobacter baumannii strain LAC-4
VINOGRADOV, E. V., MacLean, L. L., Xu, H. H., & Chen, W. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.03.001 · Cited by 45
de Léséleuc, L., Harris, G., KuoLee, R., Xu, H. H., & Chen, W. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.12.002 · Cited by 47
Hu, Y., & Coates, A. R. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks384 · Cited by 44
Brotfain, E., Borer, A., Koyfman, L., Saidel‐Odes, L., Frenkel, A., Gruenbaum, S. E., Rosenzweig, V., Zlotnik, A. A., & Klein, M. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616632193 · Cited by 41
Guillamet, C. V., Vazquez, R., Noe, J., Micek, S. T., & Kollef, M. H. (2016) · Medicine · doi:10.1097/md.0000000000004708 · Cited by 41
“Two multivariable analyses were planned: the first model included resistance to ceftriaxone as a variable, whereas the second model included the various antibiotic-resistant species (methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae).”
MethodLam, J. C., Gregson, D. B., Robinson, S., Somayaji, R., Conly, J. M., & Parkins, M. D. (2019) · Infection · doi:10.1007/s15010-019-01330-5 · Cited by 46
Niu, T., Xiao, T., Guo, L., Yu, W., Chen, Y., Zheng, B., Huang, C., Yu, X., & Xiao, Y. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s169432 · Cited by 39
Cheng, W.-L., Hsueh, P.-R., Lee, C.-C., Li, C.-W., Li, M.-J., Chang, C.-M., Lee, N.-Y., & Ko, W.-C. (2016) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2014.05.003 · Cited by 38
Poovieng, J., Sakboonyarat, B., & Nasomsong, W. (2022) · Scientific Reports · doi:10.1038/s41598-022-12904-z · Cited by 39
Zhang, W., Zhou, H., Jiang, Y., He, J., Yao, Y., Wang, J., Liu, X., Leptihn, S., Hua, X., & Yu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927955 · Cited by 37
Sianipar, O., Asmara, W., Dwiprahasto, I., & Mulyono, B. E. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4751-9 · Cited by 34
Yang, Y., Lee, Y., Huang, T.-W., Sun, J., Kuo, S., Yang, C.-H., Chen, T.-L., Lin, J., Fung, C., & Chang, F. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-142 · Cited by 37
Sécher, T., Dalloneau, E., Ferreira, M., Parent, C., Azzopardi, N., Paintaud, G., Si‐Tahar, M., & Heuzé‐Vourc'h, N. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.005 · Cited by 34
Nemeth, J., Ledergerber, B., Preiswerk, B., Nobile, A., Karrer, S., Ruef, C., & Kuster, S. P. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.08.017 · Cited by 34
Teng, S.-O., Yen, M., Ou, T.-Y., Chen, F.-L., Yu, F.-L., & Lee, W. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.06.011 · Cited by 28
Corey, G. R., Rubinstein, E., Stryjewski, M. E., Bassetti, M., & Barriere, S. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu971 · Cited by 28
“As bacteremic HAP is associated with higher mortality than nonbacteremic HAP, particularly when MRSA is the causative pathogen [41], a post hoc analysis of patients with bacteremic HAP”
Silvestri, L., Weir, W. I., Gregori, D., Taylor, N., Zandstra, D. F., Saene, J. J. M. V., & van Saene, H. K. F. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.11.005 · Cited by 26
Namikawa, H., Yamada, K., Sakiyama, A., Imoto, W., Yamairi, K., Shibata, W., Yoshii, N., Niki, M., Nakaie, K., Oinuma, K.-I., et al. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.04.008 · Cited by 28
Wu, Z., Tian, Y., Alam, H. B., Li, P. W. F., Duan, X., Williams, A. M., Liu, B., Ma, J., & Li, Y. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa475 · Cited by 30
Namikawa, H., Niki, M., Niki, M., Oinuma, K.-I., Yamada, K., Nakaie, K., Tsubouchi, T., Tochino, Y., Takemoto, Y., Kaneko, Y., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.06.027 · Cited by 32
Kunac, A., Sifri, Z. C., Mohr, A. M., Horng, H., Lavery, R. F., & Livingston, D. H. (2013) · Surgical Infections · doi:10.1089/sur.2012.030 · Cited by 26
“Our population of patients differed from that in the the multi-center European study (EU-VAP study group) in consisting exclusively of trauma patients.”
BackgroundInfluentialWagener, B. M., Hu, R.-H., Wu, S., Pittet, J., Ding, Q., & Che, P. (2021) · Toxins · doi:10.3390/toxins13110776 · Cited by 33
“aeruginosa bacteremia, a poor prognostic sign [10,11].”
Scheeren, T., Welte, T., Saulay, M., Engelhardt, M. F., Henriksen, A. S., & Hamed, K. A. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3820-y · Cited by 26
Park, S. Y., Lee, E. J., Kim, T., Yu, S. N., Park, K., Lee, M. S., Park, S. Y., Jeon, M. H., Kim, T. H., & Choo, E. J. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.10.018 · Cited by 24
Siegel, E. R., Croze, R. H., Fang, X., Matthay, M. A., & Gotts, J. E. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00046.2021 · Cited by 23
Shorr, A. F., Zilberberg, M. D., Micek, S. T., & Kollef, M. H. (2015) · Critical Care · doi:10.1186/s13054-015-1029-z · Cited by 21
“, though, included all subjects with either HAP or VAP, irrespective of pathogen [15].”
BackgroundCunningham-Oakes, E., Soren, O., Moussa, C., Rathor, G., Liu, Y., Coates, A. R. M., & Hu, Y. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01195 · Cited by 24
“Methicillin-sensitive S. aureus (MSSA) and MRSA are major causes of life-threatening infections including surgical site infections, bacteraemia, pneumonia and catheter-associated infections (Fry and Barie, 2011; Magret et al., 2011), leading to significant morbidity and mortality.”
BackgroundNamikawa, H., Niki, M., Niki, M., Yamada, K., Nakaie, K., Sakiyama, A., Oinuma, K.-I., Tsubouchi, T., Tochino, Y., Takemoto, Y., et al. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03676-y · Cited by 24
Ju, M., Hou, D., Chen, S., Wang, Y., Tang, X., Liu, J., Chen, C., Song, Y., & Li, H. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.86 · Cited by 20
Impact of multidrug-resistant bacteria on outcome in patients with prolonged weaning
Bickenbach, J., Schöneis, D., Marx, G., Marx, N., Lemmen, S., & Dreher, M. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0708-3 · Cited by 20
Choi, M. H., Kim, D., Lee, K. H., Cho, J. H., & Jeong, S. H. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106886 · Cited by 24
Yang, S., Liao, K., Chen, C., & Lin, W. (2013) · Respirology · doi:10.1111/resp.12121 · Cited by 19
Diagnosis of Multidrug-Resistant Pathogens of Pneumonia
Sfeir, M. M. (2021) · Diagnostics · doi:10.3390/diagnostics11122287 · Cited by 19
“On the other hand, a multi-center, observational, prospective study found a 14.6% rate of bacteremia in patients that were admitted with HAP or VAP [17].”
BackgroundInfluentialCulshaw, N., Glover, G. W., Whiteley, C., Rowland, K., Wyncoll, D. L. A., Jones, A., & Shankar‐Hari, M. (2014) · Annals of Intensive Care · doi:10.1186/s13613-014-0034-8 · Cited by 17
Wilson, S. E., Graham, D. R., Wang, W., BRUSS, J. B., & Castañeda-Ruiz, B. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0162-1 · Cited by 17
“The high mortality rate (approximately 40%) experienced by HABP/VABP patients with concurrent bacteremia [12] is consistent with other pneumonia studies that observed greater mortality in bacteremic HABP/VABP patients than in patients without bacteremia [3, 8].”
ResultLan, M., Dongmei, K., Guodong, S., Haifeng, Y., Guofeng, C., Mengting, C., & Xiaoyun, F. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09335-8 · Cited by 17
“As shown in Table 1, the resistance rates to imipenem, meropenem, tigecycline and colistin were 58.9%, 78.89%, 5.88% and 3.37%, respectively, which is similar to the data in the CHINET data [19].”
ResultInfluentialAlaniz, C., & Pogue, J. M. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1r221 · Cited by 15
Hindy, J.-R., Quintero-Martinez, J. A., Lahr, B. D., DeSimone, D. C., & Baddour, L. M. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2123561 · Cited by 16
“In fact, associations between higher mortality and pulmonary sources of bacteraemia, regardless of the pathogen, have been reported [38].”
BackgroundClinical effects of bacteremia in sepsis patients with community-acquired pneumonia
Kim, T. W., Lee, S.-U., Park, B., Jeon, K., Park, S., Suh, G. Y., Oh, D. K., Lee, S. Y., Park, M. H., Lee, H., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08887-5 · Cited by 21
“Variables shown to be clinically significant in previous studies [19] and obtained at the time of the ED admission were considered in the univariable and multivariable logistic regression models.”
MethodResultInfluentialCapsoni, N., Azin, G. M., Scarnera, M., Bettina, M., Breviario, R., Ferrari, L., Ferrari, C., Privitera, D., Vismara, C., Bielli, A., et al. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03692-7 · Cited by 21
“Pneumonia tends to have a lower rate of positive bacteremia compared to urinary or abdominal infections, and those with hematogenous spread, both community and hospital-acquired, have previously been described as more severe and associated with higher mortality [40, 41].”
Mechanical Ventilation Alters the Development of Staphylococcus aureus Pneumonia in Rabbit
Barbar, S. D., Pauchard, L.-A., Bruyère, R., Bruillard, C., Hayez, D., Croisier, D., Pugin, J., & Charles, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158799 · Cited by 15
“aureus VAP was more likely to be associated with bacteraemia than was pneumonia caused by other pathogens [31, 32].”
BackgroundChoi, S.-H., Cho, E. B., Chung, J.-W., & Lee, M. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.09.011 · Cited by 14
“Bacteremic pneumonia is one of the most fatal types of bacterial infection [17], whereas central line infection can be controlled relatively easily with early removal of infected devices [18].”
BackgroundZhang, W., Yao, Y., Zhou, H., He, J., Wang, J., Li, L., Gao, M., Liu, X., Shi, Y., Lin, J., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2136534 · Cited by 13
“pital environments, particularly in intensive care units and in patients with pneumonia and bacteremia [6].”
BackgroundAFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment—Efficacy and Mechanism
Dong, T., Barasa, L., Yu, X., Ouyang, W., Shao, L.-J.-Z., Quan, C., Wang, S. H., Zhang, J., Salmon, M., Tsung, A., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.97166 · Cited by 14
Management of ventilator-associated pneumonia: Need for a personalized approach
Kalwaje, E. V., & Rello, J. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1500899 · Cited by 17
“baumannii were frequently isolated from bacteremic pneumonia, typically in late-onset infections [80,81].”
BackgroundSelf-citationPauchard, L.-A., Blot, M., Bruyère, R., Barbar, S. D., Croisier, D., Piroth, L., & Charles, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187187 · Cited by 11
Yamada, K., Yanagihara, K., Araki, N., Harada, Y., Morinaga, Y., Akamatsu, N., Matsuda, J., Izumikawa, K., Kakeya, H., Yamamoto, Y., et al. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.6018 · Cited by 10
“Pneumonia was diagnosed when new persistent pulmonary infiltrates not otherwise explained appeared on chest radiographs with the presence of local purulent respiratory secretions and systemic signs of inflammatory response (16).”
BackgroundMartín‐Loeches, I. (2020) · Antibiotics · doi:10.3390/antibiotics9070380 · Cited by 13
Ekren, P. K., Töreyin, Z. N., Takır, H. B., Balcı, M. K., Gaygısız, Ü., Gürsel, G., Ergan, B., Yalçın, A., Saltürk, C., Aydoğdu, M., et al. (2017) · Tuberkuloz ve Toraks · doi:10.5578/tt.59748 · Cited by 9
Jensen, K. H., Vogelius, I. R., Moser, C. E., Andersen, E., Eriksen, J. G., Johansen, J., Farhadi, M. R., Andersen, M., Overgaard, J., & Friborg, J. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01430-w · Cited by 9
Shamim, A., Taj, A., Khanday, S. B., & Ommid, M. (2018) · International Journal of Critical Illness and Injury Science · doi:10.4103/ijciis.ijciis_8_18 · Cited by 9
“aureus.[25] Another study in ICU at Birdem also showed growth obtained from 34% of the samples yielding 632 organisms with major organism isolates as Pseudomonas spp.”
ResultWang, S., Teng, C., Chan, M.-C., Yang, K., Sheu, C., Liang, S., Huang, W.-H., Feng, J., Chen, C.-M., Weng, Z., et al. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107128 · Cited by 9
Identification of Factors Affecting Mortality in Late-Onset Ventilator-Associated Pneumonia
Hamidi, A. A., & Kescioglu, S. (2020) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2020.20005 · Cited by 8
“Bacteremia, prolonged intubation, renal insufficiency, and hemodialysis are the factors that increase the risk of mortality in hospital-acquired pneumonia [20, 27].”
BackgroundHuang, F., Shen, T., Hai, X., Xiu, H., Zhang, K., Huang, T., Chen, J., Guan, Z., Zhou, H., Cai, J., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11978 · Cited by 8
Hsu, C., Lin, P.-C., & Chen, K.-T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144223 · Cited by 7
“In patients with nosocomial pneumonia and soft tissue infection, bacteremia increased the mortality rate [21,22].”
BackgroundYamada, K., Kuwabara, G., Imoto, W., Yamairi, K., Shibata, W., Oshima, K., Yoshii, N., Nakaie, K., Niki, M., Okada, Y., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.08.013 · Cited by 7
Berre, C. L., Degrendel, M., Houard, M., Benetazzo, L., Vachée, A., Georges, H., Wallet, F., Patoz, P., Bortolotti, P., Nseir, S., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14040358 · Cited by 6
Role of multidrug-resistant bacteria in weaning from invasive mechanical ventilation
Michels-Zetsche, J. D., Gassmann, V., Jasuja, J. K., Neetz, B., Höger, P., Meis, J., Britsch, S., Sommerwerck, U., Fähndrich, S., Bornitz, F., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02694-5 · Cited by 7
“…in patients with MRSA and A. baumannii colonisation and prolonged mechanical ventilation, and was independently associated with higher mortality [24], or Agbaht et al., who showed that bacteraemic ventilator-associated pneumonia in previously hospitalised patients was more often caused by MRSA…”
BackgroundGarnacho‐Montero, J., Gutiérrez-Pizarraya, A., Lopez-García, I., Miranda, J. C., González-Galán, V., Corcia-Palomo, Y., Alonso-Araujo, I., Martín-Villén, L., Aznar, J., & Amaya‐Villar, R. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1362110 · Cited by 5
“ICU and hospital mortalities were also similar in the three groups.”
BackgroundInfluentialImpact of antimicrobial stewardship with the Xpert MRSA/SA BC assay at a tertiary hospital in Japan
Yamada, K., Imoto, W., Shibata, W., Kakuno, S., Nakaie, K., Myodo, Y., Takayama, N., Dobashi, A., Imai, M., Mitani, K., et al. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.03.021 · Cited by 5
Bouza, E., Guillen-Zabala, H., Rojas, A., Cañada, G., Cercenado, E., Sánchez‐Carrillo, C., Díez, C., Puente‐Maestu, L., Muñóz, P., & Galar, A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01517-23 · Cited by 6
“Bacteremia in patients with bNP seems to increase the risk of death (22, 28, 29, 33, 34, 38–41).”
BackgroundHyperoxia After Return of Spontaneous Circulation in Cardiac Arrest Patients
Latif, R. K., Clifford, S. P., Byrne, K. R., Maggard, B., Chowhan, Y., Saleem, J., & Huang, J. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.03.007 · Cited by 5
Zheng, M., Chen, J., Qin, G., Zhang, Z., Zhai, D., Ruan, H., Xia, T., Yue, T., & Shi, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-66989-x · Cited by 3
“The epithelial barrier breakdown would also permit P. aeruginosa to enter the blood circulation to induce bacteremia and sepsis 9 – 13 .”
Martín‐Loeches, I., Shorr, A. F., Kollef, M. H., Du, J., Losada, M. C., Paschke, A. A., DeRyke, C. A., Wong, M., Jensen, E. H., & Chen, L. F. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad225 · Cited by 3
“A strength of our multivariable analysis is that the independent predictors we identified for mortality and clinical failure had all been frequently reported in previous work, and that all of these predictors are plausible from a clinical and/or physiological perspective [27–31].”
Tran‐Dinh, A., Guiot, M., Tanaka, S., Lortat‐Jacob, B., Atchade, E., Zappella, N., Mordant, P., Castier, Y., Mal, H., Weisenburger, G., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101405 · Cited by 3
“In addition, bacteraemia has previously been shown to be an independent risk factor for mortality in nosocomial pneumonia [12], which was the most common source in our cohort.”
BackgroundRecent Advances in the Immunopathogenesis of Acinetobacter baumannii Infection
de, L., & Che, W. (2012) · InTech eBooks · doi:10.5772/28141 · Cited by 2
What We Learned From the EU-VAP/CAP Study for Severe Pneumonia
Leoni, D., Blot, S. I., Tsigou, E., & Koulenti, D. (2017) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000204 · Cited by 1
Self-citationCurrent project of management guidelines of the patients with nosocomial pneumonia in adults
Karnaushkina, M. A., Георгиевич, М. А., Dvoretckiy, L. I., Yakovlev, S. V., Babak, S. L., Fedosenko, S. V., Петровна, С. М., Razgulyeva, N. F., & Борисовна, А. А. (2017) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2017-2-60-70 · Cited by 1
Severe Burns: Pathogenesis and Prevention of Infection
Hurley, J. C. (2017) · Recent clinical techniques, results, and research in wounds · doi:10.1007/15695_2017_32 · Cited by 1
Bacteriemia por Staphylococcus aureus resistente a meticilina de origen respiratorio
Gras, A. C., Bouza, J. M. E., González, P. C., & Real, S. H. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.05.017 · Cited by 1
Emerging approaches to the treatment of ventilator-associated pneumonia
Mourvillier, B., Berra, L. M., & Wiener-Kronish, J. P. (2014) · Clinical Investigation · doi:10.4155/cli.14.18
Neutrophil-Mediated Vascular Host Defense
Kim, J. H., & Yipp, B. G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801078-5.00002-9 · Cited by 1
PHYLOGENETIC PROFILE OF ESCHERICHIA COLI CAUSING BLOODSTREAM INFECTION AND ITS CLINICAL ASPECT
Sianipar, O., Asmara, W., Dwiprahasto, I., & Mulyono, B. E. (2018) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v24i1.1152
Huang, F., Shen, T., Xin, H., Xiu, H., Zhang, K., Huang, T., Chen, J., Guan, Z., Zhou, H., Cai, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1003736/v1
Severe Hospital-Acquired Pneumonia
Sendama, W., Simpson, A. J., & Ewan, V. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00234-1
Iron Uptake in Host Defense Against Pneumonia
Michels, K. R. (2017) · doi:10.18130/v3465h
AL, S. Ö., Ertürk, A., Asuman, O. K. U. R., Kostakoğlu, U., & Yıldız, İ. E. (2024) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.2024021023
Wong, W., Ho, E., & Ling, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11611-7.00048-7
Metadata
- Authors
- Magret, M., Lisboa, T., Martin-Loeches, I., Máñez, R., Nauwynck, M., Wrigge, H., Cardellino, S., Díaz, E., Koulenti, D., Rello, J., & EU-VAP/CAP Study Group
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Bellvitge University Hospital (ES)
- Saint John's Hospital (BE)
- University Hospital Bonn (DE)
- Azienda Sanitaria Locale di Asti (IT)
- Corresponding author
- Rello, Jordi
- Venue
- Critical Care
- Published
- 2011-02-16
- Volume
- 15
- Issue
- 1
- Pages
- R62-R62
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC3221995
- OpenAlex
- W2053637196
- Cited by
- 105
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 11 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 14 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 6 · 2012: 9
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- bacteremia, nosocomial pneumonia, mortality risk factors, ICU mortality, mechanical ventilation, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, ICU length of stay, SAPS II score
- MeSH terms
- Aged, Cross Infection, Europe, Female, Humans, Intensive Care Units, Male, Middle Aged, Pneumonia, Prognosis, Prospective Studies, Respiration, Artificial, Risk Factors, Time Factors, Bacteremia, Treatment Outcome, Hospital Mortality, Pneumonia, Bacterial, Acinetobacter baumannii, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.